History Achievement  
 
 
 
 
 
 
 
 
 
 
 
 

  OUR VISION                 Farmer prosperity through Dhanuka excellence.

  OUR MISSION           Life Enrichment Through Science

  OUR OBJECTIVE

  • Serve the Indian farming community with safer, eco-friendly and quality agrochemicals.
  • Support the grower on judicious and right use technology.
  • Provide customer support services on usage and environment safety.
  • Pursue R & D oriented growth in bulk drugs.

                                           

PROFILE
  • The Dhanuka Group is a well established manufacturer / formulator of a wide range of popular pesticides; in ECs, Granules, Wettables & Dust Formulations of Insecticides, Fungicides, Weedicides, PGR, Growth Stimulant and Wetting Agents.
  • We are a quality conscious; customer friendly and eco - friendly group conscious for new, safe pesticide molecules.
  • The group is committed to provide Customer Support Services in the area of product usage, health, safety and disposals.
  • Over a span of 20 years, the group has emerged as a leading and growing Indian Group in pesticides business with conventional as well as diversified interests.
  • The group is professionally managed by a management group at the top with well defined and planned programme with willingness to achieve a targeted goal.
BRIEF HISTORY

Northern Minerals Limited ( NML ), a flagship company of Dhanuka Group, was acquired as sick unit in 1980 with a meager sales turnover of 17 million INR, is today a unit of over 900 million INR.

Dhanuka Pesticides Limited ( DPL ), was incorporated as a Public Limited Company under Indian Companies Act 1956 in the year 1985; primarily for manufacture of technical grade pesticides namely Fenvalerate and Cypermethrin. DPL entered into technical tie-up with E. I. DuPont De Nemours & Co. Inc., U S A. in the year 1992 to formulate, brand and market on exclusive and all India basis, Methomyl - Brand name Dunet 12.5 L. A 28 year old, nearly dead molecule Methomyl, which came to India third time, and finally through our Group was recognised in the Indian Market. In the first six months Dunet sales was 232 KL and in the fourth year itself the sales of Dunet touched all time high of 977 KL.

In 1984 our Group established a R & D unit named Dhanuka Agriculture Research Centre ( DARC), to carry out in-house field research in process development. DARC is recognised by Ministry of Science and Technology, Government of India.

In the year 1992 Group acquired another sick unit namely Rajasthan Insecticides and Fertilizers Co. Pvt. Ltd. ( RIFCO ), mainly to make dust formulations. This unit has crossed 10,000 MTs production in the third year itself.

The Dhanuka Pesticides Limited entered into a series of technical tie-up agreements with a number of Japanese Multinationals.

  • Takeda Chemicals Industries Ltd., Japan for Cartap Hydrochloride and Validamycin;
               
  • Mitsui Chemicals Inc., Japan for Etofenprox;
               
  • Hokko Chemicals Ind. Co. Ltd., Japan for Kasugamycin.

Cartap and Ethofenprox were already in India market for over five years without making any imprint. Dhanuka in the first year itself sold 1635 MT of Cartap Granules ( Caldan 4G ), which in the third year has crossed the mark of 4050 MT. Ethofenprox ( NUKIL 10 EC ) in the first year was 87 KL. Similarly Validamycin ( Sheathmar 3L ), a new molecule in the first year itself touched the mark of 60 KL. Kasugamycin ( Kasu - B ) is launched in the market in the year 2000 only.

On the other hand Northern Minerals Limited ( NML ) joined hands technically with Uniroyal Chemical Company Inc., U. S. A. in the year 1999 to formulate and market Carboxin ( Vitavax 75 WP ), Oxycarboxin ( Plantvax 20 EC ) and Diflubenzuron ( Dimilin 25 WP ). We are in advance negotiation stage for further MOUs with few other MNCs.

Within 17 years of its existence, the Group has diversified in Pharmaceuticals Bulk Drugs manufacture activity, Dhanuka Laboratories Pvt. Ltd. ( DLPL ) is established in 1997 to manufacture Cephalexin, Cefadroxil, 7-A.D. C. A. and Simvastatin. Within two years DLPL’s turnover is 150 million INR and is all for exports. In just two decades the group has touched a mark of 1500 million INR as Group’s turnover.